Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pirfenidone in Septic Acute Kidney Injury
NCT02530359Phase 4Unknown
- Sponsor
- Hospital Civil de Guadalajara
- Start
- Oct 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of pirfenidone in sepsis-associated acute kidney injury (SA-AKI), sponsored by Hospital Civil de Guadalajara. Status: unknown.
02
Drugs
pirfenidone
03
Conditions
sepsis-associated acute kidney injury (SA-AKI)
Beyond the preview
Go deeper on NCT02530359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02530359.